We tested the hypothesis that polymorphisms in the cocaine-and amphetamine-regulated-transcript (CART) gene is associated with the development of obesity. SUBJECTS: Five-hundred and twenty-eight subjects (325 men and 203 women) aged 49.6 AE 11.0 y with body mass index (BMI) of 26.9 AE 5.1.
Introduction
It is well documented that obesity is a familial disorder with a strong genetic component. Although family members share the same environment, which may promote overeating or an inactive lifestyle, twin studies have indicated that genetic factors play a major role in the etiology of obesity. 1 Eating behaviour is strongly influenced by the hypothalamus through several different signaling molecules and receptor systems. Cocaine-and amphetamine-regulated-transcript (CART) is a recently discovered hypothalamic peptide that represses food intake. 2 In the central nervous system CART is highly expressed in many hypothalamic nuclei. 3, 4 Peripheral administration of leptin to obese mice stimulates CART mRNA expression. 2 Intracerebroventricularly injected CART peptide dose-dependently inhibits food intake in food restricted rats 2, 5 and the feeding response induced by neuropeptide Y administration. 6 Injection of an antibody to CART peptide stimulates feeding, 6 suggesting that CART may be an endogenous inhibitor of food intake. Postprandial satiety effects of cholecystokinin may also be mediated by CART.
7
In this study we tested the hypothesis that genetic variants in the CART gene are involved in weight gain.
Subjects and methods
We studied 528 subjects (325 men and 203 women) aged 49.6 AE 11.0 y with body mass index (BMI) of 26.9 AE 5.1. These subjects were recruited from people who attended the Kumamoto Red Cross Health Care Center for health screening and gave informed consent, and patients treated at the Kurume University Hospital who gave informed consent. One-hundred and fifty-one subjects were diagnosed as having type 2 diabetes mellitus; the BMI of diabetic subjects was 29.9 AE 4.7. No patients with type 1 diabetes were included in this study.
The coding region of exon 1 of the CART gene was amplified by PCR with a sense primer 5 0 -ATAAAAGGTGG- 8 was amplified from adaptor-ligated genomic DNA library (Clontech, Palo Alto, CA, USA). Briefly, libraries of purified genomic DNA fragments ligated to adaptor linkers were amplified with a primer complementary to the adaptor and a primer complementary to nucleotides 69 -94 from the transcription start site of the CART gene using Tth polymerase (Clontech). Products were subjected to a second amplification with a nested primer complementary to the adaptors and a primer complementary to nucleotides 71 to þ 26 of the CART gene. An approximately 1.1 kb product was obtained from a genomic Dral library. The fragment was cloned in a PCR compatible TA vector (pCR2.1, Invitrogen, Carlsbad, CA, USA) and sequenced. Then we sequenced the upstream region of the CART gene from 30 obese and 30 lean subjects using three pairs of primers -a sense primer The results are presented as means and s.d. Student's unpaired t-tests were used to compare the means of two groups. Differences among the three-group means were estimated by the Kruskal -Wallis test. If a level of significance less than 0.05 was observed, Scheffe's method of multiple comparisons was used to determine differences among groups. The chi-square test was used to compare frequencies. A P-value < 0.05 was considered statistically significant.
Results

Coding regions and the 3
0 UTR of the CART gene from 30 obese (BMI ! 30) and 30 lean (BMI < 25) subjects were screened for mutations by both PCR-SSCP and PCR-direct sequencing. No mutation was found in the coding regions in either obese or lean subjects. However, a single nucleotide insertion=deletion polymorphism was identified at þ 1355 in the 3 0 UTR. In each group, seven of 30 subjects were heterozygous for the variant. No homozygote for the deleted allele was obtained in the subjects.
To assess possible contributions of promoter polymorphism of the CART gene to the development to obesity, we cloned and sequenced the 5 0 -flanking region of the CART gene ( Figure 1 ). The region included a putative cyclic AMPresponsive element (CRE) at 7136 from the transcription initiation site, and four E-box motifs between positions 7564 and 7391. We sequenced the 5 0 -flanking region of the CART gene from the 60 subjects and found six common polymorphic sites; A?G at 7156, T?C at 7390, T?G at 7484, G?T at 7915, G?C at 7929 and C?T at 7962 from the transcription initiation site. The 7484 polymorphism is located in an E-box consensus motif. The nucleotide substitution at 7156 creates a Bpml restriction site. The substitutions at 7390 and 7929 abolish an HphI site and an StyI site, respectively. We further genotyped remaining 468 subjects for the polymorphic sites of the CART gene. The most proximal site (7156) was analyzed by applying the PCRrestriction fragment length polymorphism (RFLP) method with the use of BpmI. The other five sites were analyzed by PCR-direct sequencing. The BpmI site was highly polymorphic with the variant allele frequency of 0.34. BMI was significantly associated with the CART gene polymorphism at position 7156 (P ¼ 0.035, Kruskal -Wallis test, Table 1 ). Scheffe's multiple comparison test showed that homozygotes for the 7156 variant allele had greater BMI than homozygotes for the wild type allele (P < 0.05). The frequency of the 7156
International Journal of Obesity CART polymorphism and obesity K Yamada et al variant allele was significantly higher in obese subjects (BMI ! 30) than in non-obese subjects (Table 2) . Nucleotide substitution at position 7929 was also associated with obesity. However, the 7156 and 7929 substitutions were in linkage disequilibrium with each other. Actually all but one of the subjects carrying the 7929 variant allele also had the 7156 variant. When subjects were subgrouped according to the 7156 genotype, no significant differences of genotype Figure 1 The nucleotide sequence of the human CART gene promoter region. Four E-box motifs (CANNTG), a putative cAMP-responsive element (TGACGTCA), and a potential TATA box are underlined. Polymorphic sites are indicated by bold letters. International Journal of Obesity CART polymorphism and obesity K Yamada et al and allele frequencies were noted at position 7929 between obese and non-obese subjects ( Table 3 ). Next we assessed whether the CART gene polymorphisms were associated with type 2 diabetes mellitus (Table 4) . Homozygotes for the 7156 variant allele and those for the 7929 variant allele tended to be more common in diabetic subjects than in nondiabetic subjects, although the differences did not reach statistical significance (P ¼ 0.07 for both).
Discussion
CART mRNA was originally identified by PCR differential display techniques as a transcript acutely up-regulated in rat striatum after cocaine or amphetamine administration. 9 Several lines of evidence have indicated that CART is a satiety factor closely associated with the actions of two major regulators of food intake, leptin and neuropeptide Y. 2 -7 In fa=fa rats and ob=ob mice with disrupted leptin signaling, CART mRNA is virtually absent from the arcuate nucleus. 2 However, peripheral administration of leptin to obese mice restores CART mRNA expression in ob=ob mice, 2 indicating that leptin-induced anorexia is at least partially mediated via CART neurons. Thus decreased CART tone of the hypothalamic nuclei may contribute to human obesity.
Recently, Echwald et al 10 reported that no mutation was found by screening of the coding regions of the CART gene by PCR-SSCP analysis in Danish subjects with early onset obesity. They identified two polymorphisms in the 3 0 UTR: a deletion of A at þ 1355 and an A?G substitution at þ 1373. However, neither of the variants was associated with obesity. In the present study no polymorphic site was found in the coding regions of the CART gene, in accordance with the report in Danish subjects. Thus mutations in the coding regions of the CART gene are unlikely to be involved in the common form of obesity, although the possibility remains that mutations in the coding regions are associated with a subtype of obesity. In the 3 0 UTR, we found the þ 1355 variant in our Japanese subjects. However, the variant allele frequency was equivalent between lean subjects and obese subjects (0.12 for both). The frequency was slightly higher than those in Danish obese, control and lean subjects (0.077, 0.078, 0.067, respectively). Unlike the coding regions, the putative promoter region was highly polymorphic. Of the six polymorphic sites we identified, nucleotide substitution (A?G) at 7156 was significantly associated with greater BMI. The frequency of the 7156G allele was significantly higher in obese subjects with BMI greater than 30. Although the 7929 variant allele was also more common in obese subjects than in non-obese subjects, the association can be attributable to linkage disequilibrium with 7156 polymorphism. Obesity is a major risk factor of type 2 diabetes mellitus. Frequency of type 2 diabetes tended to be higher in those homozygous for the 7156G allele, although the difference did not reach statistical significance. The tendency may be explained by the fact that most of the diabetic patients were obese.
Although the association between the 7156 polymorphism of the CART gene and obesity should be confirmed in larger studies in various ethnic groups, these observations suggest that the BpmI site or other polymorphisms in linkage disequilibrium with the BpmI site may be associated with genetic predisposition to obesity. International Journal of Obesity CART polymorphism and obesity K Yamada et al
